These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11109075)

  • 21. [Management of testicular intraepithelial neoplasia (TIN)--a review based on the principles of evidence-based medicine].
    Dieckmann KP; Classen J; Souchon R; Loy V
    Wien Klin Wochenschr; 2001 Jan; 113(1-2):7-14. PubMed ID: 11233474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracranial granulocytic sarcoma after chemotherapy for pineal germinoma and testicular cancer.
    Passarin MG; Vattemi E; Musso AM; Romito S; Moretto G; Ghimenton C; Iuzzolino P; Doglioni C; Pedersini R
    J Clin Oncol; 2008 Sep; 26(27):4507-9. PubMed ID: 18802163
    [No Abstract]   [Full Text] [Related]  

  • 23. Reducing treatment toxicities in the management of good prognosis testicular germ cell tumors.
    Gilbert DC; Van As NJ; Huddart RA
    Expert Rev Anticancer Ther; 2009 Feb; 9(2):223-33. PubMed ID: 19192960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poor-risk germ cell tumors. Recent developments.
    Dodd PM; Motzer RJ; Bajorin DF
    Urol Clin North Am; 1998 Aug; 25(3):485-93. PubMed ID: 9728218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
    Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
    J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re: Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors.
    Schatte EC; Lerner SP
    J Urol; 2000 Nov; 164(5):1670. PubMed ID: 11203071
    [No Abstract]   [Full Text] [Related]  

  • 27. Management of stage I nonseminomatous germ-cell tumors.
    Thomas J; Aleman M; Dreicer R; Klein EA
    Semin Urol Oncol; 2002 Nov; 20(4):220-6. PubMed ID: 12489053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonseminomatous germ cell tumor of the testis.
    Matthews GJ; Mordente J; Lifson B
    Urology; 1997 Jan; 49(1):117-8. PubMed ID: 9000199
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prognostic factors in patients with disseminated germ cell tumors].
    Daugaard KG; Hansen HH
    Ugeskr Laeger; 1997 Sep; 159(38):5676-7. PubMed ID: 9340877
    [No Abstract]   [Full Text] [Related]  

  • 30. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging controversies in the management of stage 1 germ cell cancers.
    Oliver RT
    BJU Int; 2003 Jul; 92(1):1-2. PubMed ID: 12823370
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of patients with stage I nonseminomal germ cell testicular tumors].
    Arutiunian NO; Figurin KM; Shabanov MA; Tiuliandin SA
    Urol Nefrol (Mosk); 1999; (2):39-42. PubMed ID: 12434442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on testicular germ cell tumors.
    Mannuel HD; Hussain A
    Curr Opin Oncol; 2009 May; 21(3):254-9. PubMed ID: 19363342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Frequency and cause of death in patients with testicular germinal tumors at our center: retrospective analysis].
    Martínez Portillo FJ; Fernández Arancibia MI; Jünemann KP; Alken P; Köhrmann KU
    Arch Esp Urol; 2002 Mar; 55(2):153-63. PubMed ID: 12014047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testicular cancer.
    Brock D; Fox S; Gosling G; Haney L; Kneebone P; Nagy C; Qualitza B
    Semin Oncol Nurs; 1993 Nov; 9(4):224-36. PubMed ID: 8290818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poor prognosis germ-cell tumors: An unresolved challenge.
    Toner GC; Frydenberg M
    Semin Urol Oncol; 2002 Nov; 20(4):251-61. PubMed ID: 12489058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of germ cell tumors at the threshold of the third millennium].
    Géczi L; Biron P; Droz JP
    Orv Hetil; 2001 Aug; 142(31):1673-9. PubMed ID: 11556261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lectin-reactive alpha-fetoprotein as a marker for testicular tumor activity.
    Kawai K; Kojima T; Miyanaga N; Hattori K; Hinotsu S; Shimazui T; Akaza H
    Int J Urol; 2005 Mar; 12(3):284-9. PubMed ID: 15828957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Update on about testicular cancer].
    Houlgatte A; Dourthe LM; Bernard O
    Bull Cancer; 2002 Jan; 89(1):47-56. PubMed ID: 11847026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testis cancer: a 20-year epidemiological review of the experience at a regional military medical facility.
    Cooper DE; L'esperance JO; Christman MS; Auge BK
    J Urol; 2008 Aug; 180(2):577-81; discussion 581-2. PubMed ID: 18554661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.